“In Silico Investigation of the Interactions of Piflufolastat F-18 and Flotufolastat F-18 Radiopharmaceuticals with Biological Targets Relevant to Prostate Cancer Diagnosis”, Rev. Sci. Santé, vol. 5, no. 1, pp. 27–34, Feb. 2026, doi: 10.71004/rss.026.v5.i1.50.